CD8A and neoplasm: In another study, anti-PD-1 antibody was given to a mouse liver cancer model and 30 Gy SBRT radiotherapy was simultaneously administered, and the results showed that the infiltration level of CD8+ T cells in tumor tissue was significantly increased, the development of tumor was significantly inhibited, and the survival rate was also improved (32).